| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 255.695 | 86 |
| GSM780708 | Untreated after 4 days (C2_1) | 222.041 | 85 |
| GSM780709 | Untreated after 4 days (C3_1) | 226.987 | 85 |
| GSM780719 | Untreated after 4 days (C1_2) | 237.938 | 85 |
| GSM780720 | Untreated after 4 days (C2_2) | 227.115 | 85 |
| GSM780721 | Untreated after 4 days (C3_2) | 235.097 | 85 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 196.23 | 83 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 236.547 | 85 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 223.719 | 85 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 216.004 | 84 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 228.671 | 85 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 216.337 | 84 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 236.593 | 85 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 204.562 | 84 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 256.726 | 86 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 236.254 | 85 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 212.73 | 84 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 227.615 | 85 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 209.89 | 84 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 213.932 | 84 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 257.6 | 86 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 217.255 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 216.556 | 84 |